ADD Medication for Children
Considering ADD medication for a child? Explore this emotional dilemma that many parents face when their child has ADD.
Alternative Treatments for ADD/ADHD [offsite link]
There are alternative treatments to manage ADD.
Facts About Stimulant Med Use and ADD
The use of stimulant medications combined with lifestyle strategies have been the treatments that show the most efficacy for the negative symptoms of Attention Deficit Disorder. Get the facts about stimulant medication and find out what researchers have to say.
Long-Acting Stimulant Meds for ADD
This week the news brought word of two new long-acting, stimulant medications approved by The US Food and Drug Administration (FDA) for Attention Deficit Disorder. One, Contempla, is aimed at children aged 6-17 years old. The other, Mydayis, was approved for ages 13-years old to adults.
Medication Chart To Treat ADD [offsite link]
Some of the drugs commonly used in the treatment of ADD are included in this chart which provides information such as dosing, side effects, and duration of action.
Natural Interventions for ADD
What happens when ADD medication isn't effective? How do you deal with Attention Deficit Disorder when you cannot afford medication and counseling or your doctor won't prescribe it? Here are some natural ways to deal with the negative effects of ADD. This article has a large list of resources.
The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition with Text Revisions (DSM-IV-TR) is used in the United States to diagnose mental health disorders. Having a common system to consult for diagnosis helps the clinician to standardize the diagnostic criteria that are examined.
Links marked with the [offsite link] designation point to websites not associated with BellaOnline.com. BellaOnline.com is not responsible for the material found there.
Editor's Picks Articles
Top Ten Articles
Content copyright © 2018 by . All rights reserved.
This content was written by . If you wish to use this content in any manner, you need written permission. Contact Connie Mistler Davidson for details.